CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

BACKGROUND: Leukemia stem cells (LSCs) are responsible for the initiation, progression, and relapse of acute myeloid leukemia (AML). Therefore, a therapeutic strategy targeting LSCs is a potential approach to eradicate AML. In this study, we aimed to identify LSC-specific surface markers and uncover...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yongliang, Wang, Guiqin, Zhang, Jiasi, Chen, Xue, Xu, Huailong, Heng, Gang, Chen, Jun, Zhao, Yongchun, Li, Jiatao, Ni, Yuanli, Zhang, Yingzi, Shan, Juanjuan, Qian, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836575/
https://www.ncbi.nlm.nih.gov/pubmed/33494824
http://dx.doi.org/10.1186/s13287-021-02155-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836575/
https://www.ncbi.nlm.nih.gov/pubmed/33494824
http://dx.doi.org/10.1186/s13287-021-02155-6

Ejemplares similares